| Trade name of the product: |
| Menactra |
| Pharmaceutical active ingredients: |
| Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate, Group AMeningococcal Polysaccharide-Diphtheria Toxoid Conjugate, Group CMeningococcal Polysaccharide-Diphtheria Toxoid Conjugate, Group W 135Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate, Group Y |
| Available forms, composition and doses of Menactra: |
| Injectable; Injection; Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate, Group A 4 mcg; Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate, Group C 4 mcg; Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate, Group W 135 4 mcg; Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate, Group Y 4 mcg / 0.5 ml |
| Medical categories: |
| Human:Vaccines, antisera and immunologicals |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J07AH08 - Meningococcus A, C, Y, W-135, tetravalent purified polysaccharides antigen conjugated |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-AventisZuellig Pharma |
| Where to buy Menactra brand or generic online: |
Buy Menactra online
|